Virios Therapeutics, Inc. (NASDAQ:VIRI - Get Free Report)'s share price fell 2.1% during mid-day trading on Monday . The stock traded as low as $5.08 and last traded at $5.18. 35,069 shares were traded during mid-day trading, a decline of 97% from the average session volume of 1,049,645 shares. The stock had previously closed at $5.29.
Virios Therapeutics Price Performance
The firm's 50-day moving average price is $4.77 and its 200-day moving average price is $5.09. The company has a market cap of $94.08 million, a price-to-earnings ratio of -18.09 and a beta of 1.58.
About Virios Therapeutics
(
Get Free Report)
Virios Therapeutics, Inc, a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia.
See Also
Before you consider Virios Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Virios Therapeutics wasn't on the list.
While Virios Therapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
